1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Colorectal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Colorectal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Colorectal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 9
Metastatic Colorectal Cancer 9
Report Guidance 9
Clinical Trials by Region 10
Clinical Trials and Average Enrollment by Country 11
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 16
Top Five Countries Contributing to Clinical Trials in Central and South America 17
Clinical Trials by G7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Unaccomplished Trials of Metastatic Colorectal Cancer 28
Subjects Recruited Over a Period of Time 39
Clinical Trials by Sponsor Type 40
Prominent Sponsors 41
Top Companies Participating in Metastatic Colorectal Cancer Therapeutics Clinical Trials 42
Prominent Drugs 44
Latest Clinical Trials News on Metastatic Colorectal Cancer 45
Apr 07, 2014: Immunomedics Reports Results From Three Phase I Trials With IMMU-130 in Metastatic Colorectal Cancer 45
Apr 06, 2014: MacroGenics Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 at the AACR Annual Meeting 45
Dec 02, 2013: AB Science announces initiation of a new phase 3 study in oncology with masitinib in patients with metastatic colorectal cancer 46
Nov 28, 2013: Alchemia Provides an Update on Progress of HA-Irinotecan 47
Nov 11, 2013: Phase III Clinical Trial Results of TS-1 on Metastatic Colorectal Cancer Published in Digital Version of The Lancet Oncology 47
Clinical Trial Profiles 49
Clinical Trial Overview of Top Companies 49
F. Hoffmann-La Roche Ltd. 49
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 49
Amgen Inc. 59
Clinical Trial Overview of Amgen Inc. 59
Sanofi 63
Clinical Trial Overview of Sanofi 63
Pfizer Inc. 66
Clinical Trial Overview of Pfizer Inc. 66
E. Merck KG 69
Clinical Trial Overview of E. Merck KG 69
Eli Lilly and Company 72
Clinical Trial Overview of Eli Lilly and Company 72
Bristol-Myers Squibb Company 74
Clinical Trial Overview of Bristol-Myers Squibb Company 74
Novartis AG 76
Clinical Trial Overview of Novartis AG 76
Bayer AG 78
Clinical Trial Overview of Bayer AG 78
AstraZeneca PLC 80
Clinical Trial Overview of AstraZeneca PLC 80
Clinical Trial Overview of Top Institutes / Government 82
National Cancer Institute 82
Clinical Trial Overview of National Cancer Institute 82
Memorial Sloan Kettering Cancer Center 88
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 88
The University of Texas M. D. Anderson Cancer Center 90
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 90
Grupo Espanol de Tratamiento de Tumores Digestivos 92
Clinical Trial Overview of Grupo Espanol de Tratamiento de Tumores Digestivos 92
Epidemiological and Clinical Research Information Network 94
Clinical Trial Overview of Epidemiological and Clinical Research Information Network 94
European Organization for Research and Treatment of Cancer 96
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 96
Gruppo Oncologico del Nord-Ovest 97
Clinical Trial Overview of Gruppo Oncologico del Nord-Ovest 97
NCIC Clinical Trials Group 98
Clinical Trial Overview of NCIC Clinical Trials Group 98
Duke University 99
Clinical Trial Overview of Duke University 99
Five Key Clinical Profiles 100
Appendix 236
Abbreviations 236
Definitions 236
Research Methodology 237
Secondary Research 237
About GlobalData 238
Contact Us 238
Disclaimer 238
Source 239

List of Tables
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 10
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 11
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 12
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 13
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 14
Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 15
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 16
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 17
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 18
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 19
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 20
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 21
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 22
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 23
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 24
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 25
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 26
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 27
Metastatic Colorectal Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 28
Metastatic Colorectal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 29
Metastatic Colorectal Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 31
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 39
Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 40
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 41
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 43
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 44
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 49
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 59
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 63
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 66
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014* 69
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 72
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 74
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 76
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 78
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 80
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 82
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 88
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 90
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Grupo Espanol de Tratamiento de Tumores Digestivos, 2014* 92
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Epidemiological and Clinical Research Information Network, 2014* 94
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 96
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gruppo Oncologico del Nord-Ovest, 2014* 97
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2014* 98
Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 99

List of Figures
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 10
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 11
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 12
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 13
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 14
Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 15
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 16
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 17
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 18
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 19
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 20
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 21
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 22
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 23
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 24
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 25
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 26
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 27
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 39
Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 40
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 41
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 42
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 44
GlobalData Methodology 237

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.